Introduction to Pharma Market Access

Share this training

New edition of CTC’s Pharma Access Course


These days, both clinical effectiveness and ‘value for money’ are essential and pharma companies must navigate an increasingly complex reimbursement landscape to make sure the product reaches the patients for whom it is intended. This course, which will take place on 25 September 2019 in Basel, provides an introduction to the dynamics and challenges of Market Access in assuring pharmaceutical brands reach the patients.


Who should attend?

This course has been designed for professionals working in the pharmaceutical industry, particularly those in Drug Development, Regulatory Affairs, Medical Affairs who want to learn about the role Market Access plays in providing access of pharmaceutical brands to patients.

Course Objectives

At the end of this course participants will be able to:

  • Understand the Market Access landscape and the challenges from a Physician, Patient, Payer and Pharma perspective
  • Explain what benefit or improved health outcomes means, including Quality of Life
  • Learn the different types of assessments of evidence for economic evaluations, including Health Technology Assessment
  • Gain understanding of pricing strategies and appreciate the country system differences



  • Introduction to Market Access
  • Landscape: Who are the Stakeholders and what are their perspectives
  • Health Outcome Assessment types
  • Pricing
  • Country systems


Course Leader

Dr Jolanda Groenhuijzen, MD is an independent consultant operating in the healthcare industry based in Basel. Prior to starting her own business, she was a seasoned healthcare industry professional: her experience includes international operational and managerial roles in Medical, Marketing and Market access for blue chip companies AstraZeneca, Pfizer and Novartis. She graduated as a Medical Doctor from the Erasmus University in Rotterdam.


Learning Methodology

Interactive sessions with a mix of lecture, case studies to illustrate the theory, exercises to test the knowledge and Q&A.



  • Early-bird Fee: CHF 880.00 + <7.7% VAT (valid until 14.08.19)
  • Registration Fee: CHF 950.00 + 7.7% VAT (valid after 14.08.19)
  • *10 % reduction for members of SwAPP and SBA

Registration fees include: Course documentation, refreshments, lunch and a course participation certificate.

More information and registration